These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 3151336

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro evaluation of Ro 23-6240, a new fluorinated 4-quinolone.
    Stobberingh EE, Houben AW, van Boven CP.
    Chemotherapy; 1987; 33(3):197-203. PubMed ID: 3109817
    [Abstract] [Full Text] [Related]

  • 3. External otitis in divers: etiology and in vitro activity of ciprofloxacin and local agents.
    Dibb WL.
    Chemioterapia; 1987 Jun; 6(2 Suppl):138-40. PubMed ID: 3509371
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative activities of three new antibacterial agents with aztreonam against gram-negative bacilli.
    Kafetzis DA, Legakis NJ.
    Chemioterapia; 1987 Jun; 6(2 Suppl):110-2. PubMed ID: 3151330
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activity of ciprofloxacin.
    Ferrara A, Donnetta A, Grassi FA, Gialdroni Grassi G.
    Chemioterapia; 1987 Jun; 6(2 Suppl):130-1. PubMed ID: 3151333
    [No Abstract] [Full Text] [Related]

  • 8. Comparative activity of three new fluoroquinolones.
    Coll R, Esteve M, Moros M, Parés J, Xicota MA.
    Chemioterapia; 1987 Jun; 6(2 Suppl):152-3. PubMed ID: 3509374
    [No Abstract] [Full Text] [Related]

  • 9. Fleroxacin (Ro 23-6240): activity in vitro against 355 enteropathogenic and non-fermentative gram-negative bacilli and Legionella pneumophila.
    Hohl P, von Graevenitz A, Zollinger-Iten J.
    J Antimicrob Chemother; 1987 Sep; 20(3):373-8. PubMed ID: 3119553
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.
    Hohl P, Lüthy-Hottenstein J, Zollinger-Iten J, Altwegg M.
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1605-8. PubMed ID: 2121095
    [Abstract] [Full Text] [Related]

  • 12. Visualization of the bactericidal action of ciprofloxacin by light microscopy.
    Förster D.
    Chemioterapia; 1987 Jun; 6(2 Suppl):135-6. PubMed ID: 3509370
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Sensitivity of bacteria isolated from non-parenteral drugs to antibiotics. III. Evaluation of sensitivity of gram-negative strains].
    Zembrzuska E.
    Acta Pol Pharm; 1981 Jun; 38(2):249-53. PubMed ID: 7032218
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.